NRG4 and metabolic dysfunction-associated steatotic liver disease: These findings are consistent with previous reports of reduced circulating NRG4 in individuals with MASLD, metabolic syndrome, gestational diabetes mellitus, chronic kidney disease, and diabetic peripheral neuropathy (29-33).